首页> 外国专利> FABRICATION OF PHAGE NANOBIOPARTICLES AGAINST BURN WOUND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIONS

FABRICATION OF PHAGE NANOBIOPARTICLES AGAINST BURN WOUND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) INFECTIONS

机译:抗烧伤耐甲氧西林金黄色葡萄球菌(MRSA)感染的噬菌体纳米微粒的制备

摘要

Despite advances in the field of control and treatment of burn wounds but infection is the main cause of mortality in burn patients. Control and treatment of infected wound are one of the main problems due to increased strains MDR (multi drug resistance) as methicillin-resistant staphylococcal aureus (MRSA). According to increased multidrug resistance (MDR) and the return of infections need a new product to treatment of infection. Lytic bacteriophages and their products as endolysin are suggested. In order to optimal using of bacteriophages in the field of nanomedicine the phage display technique is used. The results showed phage nanobioparticles have lytic activity on MRSA In vitro, and phage nanobioparticle gel has lytic activity on MRSA In vivo. After 30 days was observed reepithelization, scar formation, fibroblast maturation, collagen deposition, granulation tissue, neovascularization in the infected group and treated with phage nanobioparticle gel.
机译:尽管在烧伤创口的控制和治疗领域取得了进步,但感染是烧伤患者死亡的主要原因。感染的伤口的控制和治疗是由于耐甲氧西林金黄色葡萄球菌(MRSA)的菌株MDR(多药耐药性)增加而引起的主要问题之一。根据增加的多药耐药性(MDR)和感染的返回,需要一种新的产品来治疗感染。建议使用溶菌性噬菌体及其产物作为内溶素。为了在纳米医学领域最佳地使用噬菌体,使用了噬菌体展示技术。结果表明,噬菌体纳米生物颗粒在体外对MRSA具有裂解活性,噬菌体纳米生物凝胶在体内对MRSA具有裂解活性。 30天后,在感染组中观察到再上皮化,瘢痕形成,成纤维细胞成熟,胶原沉积,肉芽组织,新血管形成,并用噬菌体纳米生物颗粒凝胶治疗。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号